Harvard Spinout Obtains Exclusive Rights to University's Portfolio of Black Silicon Patents, Aims to Revolutionize Photonics

Lacking any new multi-billion dollar “wonder drugs,” the big global pharmaceutical companies are turning increasingly to small biotech firms to help boost future profits.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3722463 for the full story.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3697635 for the full story.

GlaxoSmithKline has reorganized its corporate structure to put an increased focus on emerging markets. A new management group was given the charge of increasing business in the Emerging Markets, defined as China, Russia, Brazil, India and the Middle East. Even though the countries are not closely linked geographically, GSK believes the structure of the pharmaceutical markets in each nation is very similar, allowing for a unified strategy. The move was taken because of the growth for pharmaceuticals expected in these countries.  More details...

Stock Symbol: (NYSE: GSK) (NSDQ: SIRT)

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3580086 for the full story.

Major indices closed up the week here the details:
Nasdaq 0,8%
Dow Jones 0,4%
S&P 500 0,5%

Here The Weekly Movers:

GAINERS
Progenics Pharmaceuticals, Inc. (PGNX)
Sirtris Pharmaceuticals Inc. (SIRT)
General Steel Holdings, Inc. (GSI)
Volterra Semiconductor Corporation (VLTR)
Excel Maritime Carriers Ltd (EXM)
Ultratech, Inc. (UTEK)
LOSERS
Omnicell, Inc. (OMCL)
NewMarket Corporation (NEU)
National City Corporation (NCC)
RPC, Inc. (RES)
Symmetry Medical Inc. (SMA)
Lee Enterprises, Incorporated (LEE)

UPGRADES

Jo-Ann Stores JAS KeyBanc Capital Mkts Hold » Buy
Ventana Medical VMSI Caris & Company Average » Above Average
Cousins Prop CUZ Wachovia Mkt Perform » Outperform
Maxygen MAXY Stanford Research Hold » Buy
SL Green Rlty SLG KeyBanc Capital Mkts Hold » Buy
Ariba ARBA Cowen & Co Underperform » Outperform
Motorola MOT RBC Capital Mkts Sector Perform » Outperform
Susser SUSS JP Morgan Neutral » Overweight
EMC Corp EMC Citigroup Hold » Buy
Optium OPTM Jefferies & Co Hold » Buy


DOWNGRADES

Mattson MTSN CIBC Wrld Mkts Sector Perform » Sector Underperform
Cubic CUB BB&T Capital Mkts Hold » Underweight
Dime Community DCOM Stifel Nicolaus Hold » Sell
F5 Networks FFIV Nollenberger Capital Buy » Neutral
Foundry Ntwks FDRY Nollenberger Capital Buy » Neutral
Kyphon KYPH Piper Jaffray Outperform » Market Perform
LDK Solar LDK CIBC Wrld Mkts Sector Outperform » Sector Perform
Sirtris Pharma SIRT JP Morgan Overweight » Neutral
Rockwell Automation ROK JP Morgan Overweight » Neutral
Red Hat RHT Credit Suisse Outperform » Neutral
Reliance Steel RS UBS Buy » Neutral

NOTE: all casts provide both a grade and rank. Please visit the website for more details. In this week's cast Mr. Gaskins provides analysis of: Amicus Thera (FOLD) a clinical-stage pharmaceutical Company. C, 6 Jazz Pharma (JAZZ) a firm providing neurological and psychiatric products: C, 6.5 and rounding out the field is LDK Solar (LDK) who produces multicrystalline wafers for solar cells B-, 8


Other companies mentioned are: (BGS) (CLNE) (GLRE) (HLCS) (RRR) (SIRT)

This week Mr Gaskins provides analysis of a solid group of IPOs. Each analysis provides his grade and rank. Be sure to visit the IPO Desktop website for details and become a member.

First on deack is B&G Foods (BGS) a company in the shelf-stable food products business: Gade C+ and rank 7. Clean Energy Fuels (CLNE) is developing technology for natural gas & alternative fuel for vehicles: C+, 7. Greenlight Capital (GLRE) provides property & casualty reinsurance: C+, 7. Helicos BioSci (HLCS) creates genetic analysis technologies: C, 6

RSC Holdings (RRR) is in the equipment rental business: C+, 7. Rounding out the list are a pair of companies that provide labratory information managment systems: Sirtris Pharma (SIRT) C, 6. and STARLIMS (LIMS) C+, 7

Mr Gaskins aslo provides a brief update on last week's IPOs (CLR) (CSUN) (COMV) (EURX) (TTGT) (TRS)